» Articles » PMID: 24707257

Oncocytoma of the Parotid Gland: a Case Report and Review of the Literature

Overview
Journal Case Rep Oncol
Publisher Karger
Specialty Oncology
Date 2014 Apr 8
PMID 24707257
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

We report the case of a patient who presented to the ENT service with left facial swelling of 5 months duration. Imaging studies revealed a dense expansive mass confined to the inside of the left deep parotid lobule and moderate enhancement following contrast media injection. Subsequently, a biopsy confirmed the presence of an oncocytoma. The patient was treated with total parotidectomy, complete tumor resection and sparing facial nerve surgery. Today, the patient is disease free and has no complications.

Citing Articles

Salivary Gland Oncocytomas. A Systematic Review.

Alberto P, Ashim S, Megan K, Wei Z, Nestor G, Matthew Z Head Neck Pathol. 2024; 18(1):126.

PMID: 39614964 PMC: 11608208. DOI: 10.1007/s12105-024-01730-6.


Bilateral Parotid Gland Oncocytoma Mimicking Oropharyngeal Cancer Metastasis: A Case Report from a Radiation Oncologist's Perspective.

Lee S, Park W, Jung D Cancer Diagn Progn. 2024; 4(6):814-818.

PMID: 39502619 PMC: 11534040. DOI: 10.21873/cdp.10401.


Incidentally Detected 131-Iodine Avid Parotid Oncocytoma Coexistent with Papillary Carcinoma Thyroid.

Menon N, Arora S, Dabas S, Sharma A, Ranjan R, Gurung B Indian J Otolaryngol Head Neck Surg. 2023; 75(3):2598-2603.

PMID: 37636641 PMC: 10447823. DOI: 10.1007/s12070-023-03804-3.


Advanced magnetic resonance imaging findings in salivary gland tumors.

Gokce E, Beyhan M World J Radiol. 2022; 14(8):256-271.

PMID: 36160835 PMC: 9453317. DOI: 10.4329/wjr.v14.i8.256.


Sine Qua Non: Oncocytoma.

Rivera R, Nelson B Head Neck Pathol. 2022; 16(4):1167-1171.

PMID: 35834095 PMC: 9729656. DOI: 10.1007/s12105-022-01462-5.


References
1.
Armstrong J, Harrison L, Thaler H, Fass D, Zelefsky M, Shah J . The indications for elective treatment of the neck in cancer of the major salivary glands. Cancer. 1992; 69(3):615-9. DOI: 10.1002/1097-0142(19920201)69:3<615::aid-cncr2820690303>3.0.co;2-9. View

2.
Gillespie M, Albergotti W, Eisele D . Recurrent salivary gland cancer. Curr Treat Options Oncol. 2012; 13(1):58-70. DOI: 10.1007/s11864-011-0174-0. View

3.
Surakanti S, Agulnik M . Salivary gland malignancies: the role for chemotherapy and molecular targeted agents. Semin Oncol. 2008; 35(3):309-19. DOI: 10.1053/j.seminoncol.2008.03.009. View

4.
Srinivasan A, Dvorak R, Perni K, Rohrer S, Mukherji S . Differentiation of benign and malignant pathology in the head and neck using 3T apparent diffusion coefficient values: early experience. AJNR Am J Neuroradiol. 2007; 29(1):40-4. PMC: 8119114. DOI: 10.3174/ajnr.A0743. View

5.
Agulnik M, Cohen E, Cohen R, Chen E, Vokes E, Hotte S . Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and/or erbB2 expressing adenoid cystic carcinoma and non adenoid cystic carcinoma malignant tumors of the salivary glands. J Clin Oncol. 2007; 25(25):3978-84. DOI: 10.1200/JCO.2007.11.8612. View